Riskpilot← Back to searchSign inGet full accessBODIN LEGEKONTOR AS
ASActiveOrg 917934738Østensenveien 9, 8009 BodøGeneral medical practice activities · NACE 8621Est. 20165 employees
Revenue 2024
NOK 6,6M
+22% vs 2023
EBITDA margin
5.7%
+186% vs 2023
Equity ratio
61.5%
Financial strength
Net profit 2024
NOK 268K
+148% vs 2023
| Revenue | NOK 6,6M | +22% |
| EBITDA | NOK 381K | +186% |
| Net profit | NOK 268K | +148% |
| Total assets | NOK 1,5M | -6% |
| Equity | NOK 929K | +41% |
| Employees | 5 | — |
Legal name
BODIN LEGEKONTOR AS
Org number
917934738
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. oktober 2016
Share capital
NOK 40 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av legesenter i bodø kommune, investering og deltakelse i eiendom og andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Østensenveien 9, 8009 Bodø
Phone
+4775507040
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 314 | 5 384 | 5 911 | 5 415 | 6 627 |
| Staff expenses | −2 419 | −2 520 | −2 520 | −2 957 | −3 139 |
| EBITDA | 346 | 313 | 735 | −445 | 381 |
| Depreciation & amort. | −46 | −98 | −128 | −115 | −115 |
| EBIT | 300 | 215 | 607 | −561 | 265 |
| Net financials | −0 | −3 | 0 | −1 | 3 |
| Profit before tax | 300 | 213 | 607 | −562 | 268 |
| Tax | 68 | 47 | 133 | −9 | −0 |
| Net profit | 232 | 166 | 473 | −553 | 268 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 253 | 1 224 | 1 802 | 1 612 | 1 510 |
| Equity | 576 | 741 | 1 215 | 661 | 929 |
| Long-term debt | 2 | 3 | 9 | 0 | 0 |
| Short-term debt | 675 | 479 | 579 | 951 | 581 |
| Total debt | 678 | 482 | 587 | 951 | 581 |
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
20202024
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
20202024
Return on equity
28.8%
This company
18.4%
Market median
+57% vs market
20202024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20202024
Asset turnover
4.39×
This company
1.12×
Market median
+292% vs market
20202024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LC Chief Executive Officer | Chief Executive Officer | 2016 |
LC Chief Executive Officer | Chief Executive Officer | 2016 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BODIN LEGEKONTOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Cecilia Holmvik | Chief Executive Officer | 0 companies |
| Lena Cecilia Sivertsen | Chief Executive Officer | 0 companies |